Eloxx Pharmaceuticals

Business Area(s): 
Description: 

A global biopharmaceutical company focused on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Eloxx is harnessing the science of genetic read-through to develop novel drug product candidates that interact with the ribosome to overcome these premature stop codons and restore production of full-length functional proteins with the goal of enabling a return toward normal cellular function.

Location(s): 
USA
Waltham MA
United States
Israel
Rehovot
Israel